When I explain my research interests to new acquaintances, I’m often asked questions like “what would you do if you met a ...

In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...

Taxidermied, locked behind plexiglass and spinning slowly on a wooden dais in the National Museum of Scotland in Edinburgh, UK, the world’s most famous ewe remains a public spectacle three decades ...

Biotech investors are far more selective than they were during the pandemic-era boom, JPMorgan's top EMEA healthcare investment bankers told CNBC. Many biotech companies are now pursuing a dual-track ...

Elon Musk's SpaceX may be igniting global headlines with the company's astronomical IPO, but biotech listings saw their own record-breaker this week. Parabilis Medicines secured $670 million when it ...

In its annual Biotech Beyond Borders report, EY projects growth to continue throughout 2026, fueled primarily by the increased volume and value of M&A and licensing deals. (Techa Tungateja/GettyImages ...

The public biotech universe has shrunk by more than 20% since 2021, yet financial stress remains entrenched across the sector, according to a report from EY Tuesday. Hundreds of public biotech ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The transactions include upfront ...